Raleigh News & Observer Logo

Furiex is considering all its options | Raleigh News & Observer

×
  • E-edition
    • Customer Service
    • Support
    • Contact Us
    • About Us
    • FAQ
    • Sponsorships
    • Stay connected
    • Mobile & Apps
    • Facebook
    • Google+
    • Instagram
    • Twitter
    • Social Media Directory
    • N&O Store
    • Buy Photos
    • Databases
    • Archives
    • Newsletters

    • Blogs
    • Columnists
    • Crime
    • Education
    • Health
    • Local
    • North Carolina
    • Nation/World
    • Science
    • Thumbs Up
    • Traffic
    • Weather
    • Weird News
    • All News
    • Counties
    • Durham County
    • Johnston County
    • Orange County
    • Wake County
    • All Sports
    • Baseball
    • Canes
    • College
    • Columns & Blogs
    • High Schools
    • NASCAR & Auto Racing
    • NBA
    • NFL
    • NHL
    • Olympics
    • Outdoors
    • Panthers
    • Soccer
    • Schools
    • Duke
    • East Carolina
    • NC State
    • North Carolina
    • All Politics
    • The North Carolina Influencer Series
    • State Politics
    • Blogs
    • Columnists
    • PolitiFact
    • PolitiFact NC
    • Rob Christensen
    • Under the Dome
    • All Business
    • Blogs
    • Columnists
    • Health Care
    • Personal Finance
    • Real Estate
    • Shop Talk
    • Stocks Center
    • Technology
    • All Living
    • Video Now
    • Best-Kept Secrets
    • Blogs
    • Celebrations
    • Comics
    • Family
    • Fashion
    • Fitness
    • Food
    • Games and Puzzles
    • Home and Garden
    • Horoscopes
    • Mouthful
    • Past Times
    • Pets
    • Religion
    • Travel
    • Video Now
    • Arts News
    • ArtsNow
    • Books
    • Contests
    • Dining
    • Entertainment
    • Games
    • Movies
    • Music
    • Nightlife
    • Television
    • On the Beat
    • Happiness is a Warm TV
    • All Opinion
    • Columnists
    • Dwane Powell
    • Editorials
    • Influencers Opinion
    • Letters
    • Opinion Shop Blog
    • Other Views
    • Submit a Letter
  • Obituaries

    • Advertise with us
    • Place Ad
    • Apartments
    • Cars
    • Homes
    • Jobs
    • Legals
    • Obits/In Memoriams
    • Weddings
    • Today's Daily Deal
    • Special Sections
    • Today's Circulars
    • Rewards
    • Photo Store
  • Classifieds
  • Jobs
  • Moonlighting
  • Cars
  • Homes
  • Legals

Business

Furiex is considering all its options

By David Ranii -

    ORDER REPRINT →

March 12, 2014 12:17 PM

Shares of Furiex Pharmaceuticals fell 6 percent Wednesday after the company said it is examining its strategic options.

Last month, Bloomberg News, citing people with knowledge of the situation, reported that the company had retained Bank of America to find a buyer.

But on Wednesday, the company’s chairman, Fred Eshelman, said during a conference call to discuss fourth-quarter earnings: “We continue to evaluate all strategic options that might be available for the company.”

Possibilities cited by the company include launching on its own its experimental treatment for irritable bowel syndrome, eluxadoline, after obtaining regulatory approval; as well as possibly seeking a strategic partnership.

Sign Up and Save

Get six months of free digital access to The News & Observer

SUBSCRIBE WITH GOOGLE

#ReadLocal

“I don’t think we have ruled anything off the table,” Eshelman said.

Furiex shares closed at $87.87, down $5.36, on Wednesday even though the company reported better-than-expected fourth-quarter financial results after the markets closed Tuesday.

Furiex shares have more than doubled this year. Its stock jumped 130 percent on a single day last month after the company posted encouraging test results for eluxadoline.

Eshelman said that the company remains on track to submit a new drug application for eluxadoline by the end of June.

In the fourth quarter, revenue from milestone and royalty payments totaled $13.1 million, versus $9.2 million a year ago.

The company’s net loss totaled $6.5 million, or 63 cents per share, an improvement from a $9.1 million loss a year ago. Analysts were expecting the company to post a per-share loss of $1.06, according to Bloomberg News.

For all of 2013, Furiex posted a net loss of $29.6 million, or $2.92 per share, on revenue of $45 million. The company spent $82.7 million on research and development last year.

Staff writer David Ranii

  Comments  

Videos

Gene therapy company doubles plans for RTP jobs after receiving incentives

Durham proposing higher density to ease housing concerns

View More Video

Trending Stories

What to Watch on Sunday: An all-star tribute to Elvis Presley’s ’68 Comeback Special

February 17, 2019 07:00 AM

Bladen County operative ‘told us what we were to say’ at hearing, worker testifies

February 18, 2019 06:00 AM

How does UNC plan to defend Duke’s Zion Williamson? Roy Williams and players weigh-in.

February 18, 2019 05:08 PM

Bunch of jerks? Not the Hurricanes having fun

February 17, 2019 09:55 AM

Operative at center of NC election fraud hearing won’t testify

February 18, 2019 02:16 PM

Read Next

Gene therapy company doubles plans for RTP jobs after receiving incentives
Video media Created with Sketch.

Business

Gene therapy company doubles plans for RTP jobs after receiving incentives

By Zachery Eanes

    ORDER REPRINT →

February 18, 2019 12:14 PM

AveXis, a clinical-stage gene therapy company that makes treatments for spinal muscular atrophy, plans more jobs in Research Triangle Park in Durham County. It would be eligible for an incentives package.

KEEP READING

Sign Up and Save

#ReadLocal

Get six months of free digital access to The News & Observer

SUBSCRIBE WITH GOOGLE

MORE BUSINESS

Another high-rise tower is planned for downtown Raleigh

Business

Another high-rise tower is planned for downtown Raleigh

February 18, 2019 11:26 AM

Business

New Zealand leader says no final decision on using Huawei

February 18, 2019 10:24 PM
China accuses US of trying to block its tech development

Business

China accuses US of trying to block its tech development

February 18, 2019 10:17 PM
New Zealand plans new tax for giants like Google, Facebook

Business

New Zealand plans new tax for giants like Google, Facebook

February 18, 2019 09:38 PM

News

New Mexico weighs requirement for no-cost contraceptives

February 18, 2019 09:07 PM

Business

Medtronic says deaths omitted from analysis of paclitaxel-coated device

February 18, 2019 03:00 AM
Take Us With You

Real-time updates and all local stories you want right in the palm of your hand.

Icon for mobile apps

Raleigh News & Observer App

View Newsletters

Subscriptions
  • Start a Subscription
  • Customer Service
  • eEdition
  • Vacation Hold
  • Pay Your Bill
  • Rewards
Learn More
  • About Us
  • Contact Us
  • Newsletters
  • News in Education
  • Triangletoday.com
  • Legal Notices
Advertising
  • Advertise With Us
  • About Our Ads
  • Place a Classified
  • Local Deals
  • N&O Store
  • N&O Photos
Copyright
Commenting Policy
Report News
Privacy Policy
Terms of Use


Back to Story